

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 9.28211882 |
| 2 | retinal rod cell development (GO:0046548) | 8.33719112 |
| 3 | cellular potassium ion homeostasis (GO:0030007) | 8.30003012 |
| 4 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 8.12011101 |
| 5 | relaxation of smooth muscle (GO:0044557) | 8.05192760 |
| 6 | sodium ion export (GO:0071436) | 7.50499293 |
| 7 | positive regulation of synapse maturation (GO:0090129) | 7.49197267 |
| 8 | response to pheromone (GO:0019236) | 7.47990190 |
| 9 | potassium ion homeostasis (GO:0055075) | 7.01286832 |
| 10 | urinary tract smooth muscle contraction (GO:0014848) | 6.77702357 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 6.05810674 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 5.92575393 |
| 13 | regulation of synapse maturation (GO:0090128) | 5.88440739 |
| 14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.75910207 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 5.65915899 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 5.65915899 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.65915899 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.65915899 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.65915899 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 5.65915899 |
| 21 | synaptic vesicle endocytosis (GO:0048488) | 5.34416831 |
| 22 | mating behavior (GO:0007617) | 5.18440074 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.13061695 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.00574456 |
| 25 | cellular sodium ion homeostasis (GO:0006883) | 4.98230112 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.93796643 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.90346433 |
| 28 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.89904675 |
| 29 | cell communication by electrical coupling (GO:0010644) | 4.84110028 |
| 30 | leukotriene biosynthetic process (GO:0019370) | 4.78261768 |
| 31 | response to peptidoglycan (GO:0032494) | 4.78061285 |
| 32 | iron coordination entity transport (GO:1901678) | 4.71320499 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.64823780 |
| 34 | protein localization to synapse (GO:0035418) | 4.58169451 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.47329617 |
| 36 | potassium ion export (GO:0071435) | 4.42956477 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.41649754 |
| 38 | retinal cone cell development (GO:0046549) | 4.31369804 |
| 39 | innervation (GO:0060384) | 4.19530093 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19027158 |
| 41 | negative regulation of cell killing (GO:0031342) | 4.19027158 |
| 42 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.18296862 |
| 43 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.18296862 |
| 44 | detection of external biotic stimulus (GO:0098581) | 4.16301994 |
| 45 | leukotriene metabolic process (GO:0006691) | 4.14843544 |
| 46 | calcium ion import (GO:0070509) | 4.05693979 |
| 47 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 4.00603903 |
| 48 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 4.00603903 |
| 49 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.99509107 |
| 50 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.93100853 |
| 51 | striatum development (GO:0021756) | 3.92510634 |
| 52 | cellular extravasation (GO:0045123) | 3.90927528 |
| 53 | macrophage activation (GO:0042116) | 3.82918898 |
| 54 | synaptic vesicle transport (GO:0048489) | 3.80349426 |
| 55 | establishment of synaptic vesicle localization (GO:0097480) | 3.80349426 |
| 56 | glycolytic process (GO:0006096) | 3.79148686 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.77438109 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 3.76377958 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.75366298 |
| 60 | positive regulation of TOR signaling (GO:0032008) | 3.75129453 |
| 61 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.73500992 |
| 62 | germinal center formation (GO:0002467) | 3.72637447 |
| 63 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.69143258 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.67749871 |
| 65 | synaptic vesicle maturation (GO:0016188) | 3.67567329 |
| 66 | microglial cell activation (GO:0001774) | 3.66075657 |
| 67 | negative regulation of myotube differentiation (GO:0010832) | 3.65833640 |
| 68 | axon cargo transport (GO:0008088) | 3.65067069 |
| 69 | membrane depolarization during action potential (GO:0086010) | 3.64538494 |
| 70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.62994391 |
| 71 | layer formation in cerebral cortex (GO:0021819) | 3.62676025 |
| 72 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.61806767 |
| 73 | glutamate receptor signaling pathway (GO:0007215) | 3.60371976 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.60043321 |
| 75 | anterograde axon cargo transport (GO:0008089) | 3.59223904 |
| 76 | positive regulation of gastrulation (GO:2000543) | 3.59126851 |
| 77 | eye photoreceptor cell development (GO:0042462) | 3.59087152 |
| 78 | response to host defenses (GO:0052200) | 3.58470587 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.58470587 |
| 80 | response to host (GO:0075136) | 3.58470587 |
| 81 | nitric oxide mediated signal transduction (GO:0007263) | 3.57850189 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57335627 |
| 83 | detection of biotic stimulus (GO:0009595) | 3.53608496 |
| 84 | detection of other organism (GO:0098543) | 3.51578151 |
| 85 | photoreceptor cell development (GO:0042461) | 3.51213409 |
| 86 | peristalsis (GO:0030432) | 3.51154355 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.50524054 |
| 88 | response to acidic pH (GO:0010447) | 3.49848202 |
| 89 | detection of temperature stimulus (GO:0016048) | 3.49721915 |
| 90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48972039 |
| 91 | response to host immune response (GO:0052572) | 3.48972039 |
| 92 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48951502 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 3.48621430 |
| 94 | protein-chromophore linkage (GO:0018298) | 3.47627625 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46963006 |
| 96 | defense response to protozoan (GO:0042832) | 3.45366043 |
| 97 | prepulse inhibition (GO:0060134) | 3.42463473 |
| 98 | positive regulation of calcium ion import (GO:0090280) | 3.42242709 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.41521209 |
| 100 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.39941431 |
| 101 | response to muramyl dipeptide (GO:0032495) | 3.39075446 |
| 102 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.37157755 |
| 103 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.37157755 |
| 104 | regulation of synaptic vesicle transport (GO:1902803) | 3.32368940 |
| 105 | negative regulation of circadian rhythm (GO:0042754) | 3.32045145 |
| 106 | long term synaptic depression (GO:0060292) | 3.32001979 |
| 107 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31016129 |
| 108 | myeloid cell activation involved in immune response (GO:0002275) | 3.30965651 |
| 109 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.29822505 |
| 110 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.28995181 |
| 111 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.27638469 |
| 112 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.27617777 |
| 113 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.27617777 |
| 114 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.26994226 |
| 115 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.24198671 |
| 116 | regulation of macrophage cytokine production (GO:0010935) | 3.21359297 |
| 117 | cGMP biosynthetic process (GO:0006182) | 3.20514140 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19323347 |
| 119 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.19114220 |
| 120 | regulation of necroptotic process (GO:0060544) | 3.18784443 |
| 121 | pyrimidine dimer repair (GO:0006290) | 3.17493847 |
| 122 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.16281582 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 3.15897732 |
| 124 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.14195689 |
| 125 | regulation of neurotransmitter secretion (GO:0046928) | 3.11974811 |
| 126 | neutrophil mediated immunity (GO:0002446) | 3.11500831 |
| 127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10879830 |
| 128 | regulation of glucocorticoid secretion (GO:2000849) | 3.09296339 |
| 129 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07854318 |
| 130 | membrane hyperpolarization (GO:0060081) | 3.06932710 |
| 131 | regulation of neurotransmitter transport (GO:0051588) | 3.06720708 |
| 132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05694117 |
| 133 | lactate metabolic process (GO:0006089) | 3.04982287 |
| 134 | regulation of mast cell activation (GO:0033003) | 3.04225058 |
| 135 | positive regulation of interferon-alpha production (GO:0032727) | 3.04051709 |
| 136 | neutrophil activation (GO:0042119) | 3.04017440 |
| 137 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03321043 |
| 138 | photoreceptor cell maintenance (GO:0045494) | 3.02962216 |
| 139 | atrial cardiac muscle cell action potential (GO:0086014) | 3.02217415 |
| 140 | positive regulation of potassium ion transport (GO:0043268) | 3.00729673 |
| 141 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00495215 |
| 142 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99947197 |
| 143 | membrane repolarization (GO:0086009) | 2.98775732 |
| 144 | sodium ion homeostasis (GO:0055078) | 2.97747613 |
| 145 | I-kappaB phosphorylation (GO:0007252) | 2.97695849 |
| 146 | synapse assembly (GO:0007416) | 2.97580279 |
| 147 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.96270877 |
| 148 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.96270877 |
| 149 | cell communication involved in cardiac conduction (GO:0086065) | 2.96258254 |
| 150 | relaxation of muscle (GO:0090075) | 2.95953531 |
| 151 | response to protozoan (GO:0001562) | 2.95769719 |
| 152 | response to interleukin-15 (GO:0070672) | 2.95388813 |
| 153 | negative regulation of interleukin-6 production (GO:0032715) | 2.93598807 |
| 154 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93463079 |
| 155 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92579790 |
| 156 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.92305984 |
| 157 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.91932023 |
| 158 | detection of bacterium (GO:0016045) | 2.91123695 |
| 159 | T cell homeostasis (GO:0043029) | 2.90364668 |
| 160 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.89618410 |
| 161 | regulation of bile acid biosynthetic process (GO:0070857) | 2.88907185 |
| 162 | positive regulation of macrophage cytokine production (GO:0060907) | 2.88907128 |
| 163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88425521 |
| 164 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.87059571 |
| 165 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86814713 |
| 166 | nonmotile primary cilium assembly (GO:0035058) | 2.86523457 |
| 167 | cellular response to interleukin-15 (GO:0071350) | 2.82412881 |
| 168 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81184128 |
| 169 | B cell homeostasis (GO:0001782) | 2.81048506 |
| 170 | regulation of interferon-alpha production (GO:0032647) | 2.80478799 |
| 171 | cellular response to type I interferon (GO:0071357) | 2.78683419 |
| 172 | type I interferon signaling pathway (GO:0060337) | 2.78683419 |
| 173 | positive regulation of B cell differentiation (GO:0045579) | 2.78651730 |
| 174 | negative regulation of B cell mediated immunity (GO:0002713) | 2.78241515 |
| 175 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.78241515 |
| 176 | response to type I interferon (GO:0034340) | 2.75778865 |
| 177 | respiratory burst (GO:0045730) | 2.73296883 |
| 178 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.72217687 |
| 179 | immunoglobulin mediated immune response (GO:0016064) | 2.67948951 |
| 180 | positive regulation of mast cell activation (GO:0033005) | 2.67869573 |
| 181 | negative regulation of B cell proliferation (GO:0030889) | 2.66701114 |
| 182 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.64944365 |
| 183 | leukocyte aggregation (GO:0070486) | 2.64939087 |
| 184 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.64886224 |
| 185 | granulocyte activation (GO:0036230) | 2.64413368 |
| 186 | regulation of guanylate cyclase activity (GO:0031282) | 2.63153421 |
| 187 | regulation of female receptivity (GO:0045924) | 2.61370279 |
| 188 | positive regulation of interferon-beta production (GO:0032728) | 2.61288384 |
| 189 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.61113069 |
| 190 | myeloid leukocyte activation (GO:0002274) | 2.59973479 |
| 191 | myeloid leukocyte mediated immunity (GO:0002444) | 2.59601837 |
| 192 | regulation of B cell differentiation (GO:0045577) | 2.58459234 |
| 193 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.58387698 |
| 194 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.6666056 |
| 195 | detection of light stimulus involved in visual perception (GO:0050908) | 11.6666056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.05240303 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.85912536 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.39802809 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.90039296 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.83059638 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.77846002 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.69483250 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.31944615 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.13293295 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.05073164 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04223583 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95637962 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92580898 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.83389963 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74960743 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74262657 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.66088761 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.63419276 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.61823569 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58535161 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56540337 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.54786345 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.52123883 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.50594355 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44462144 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.43721300 |
| 27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.40589739 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40524202 |
| 29 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 2.40437652 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.40032364 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.37995662 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37839584 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35860754 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.31154822 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28087451 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27979923 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25472191 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22908692 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21113269 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19970728 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 2.17742012 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.15103189 |
| 43 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.14831678 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12117674 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12052567 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.11807704 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09409323 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07068448 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 2.06972549 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06158655 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05283826 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01494268 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99583450 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98826063 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.98523320 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96509574 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.96025451 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94686540 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94229467 |
| 60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94229467 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93541240 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88620934 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.88605044 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.85593883 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84469401 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.83366130 |
| 67 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80770682 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80362043 |
| 69 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77175612 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.76594338 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76287241 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75219499 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74305126 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.72833154 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72200561 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70696516 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66521187 |
| 78 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61556146 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61453571 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61011367 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59292195 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59281181 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.56311027 |
| 84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55719729 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54196876 |
| 86 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53940090 |
| 87 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.53331473 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52907925 |
| 89 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50202731 |
| 90 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49226262 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48559480 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47759332 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46089324 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44957675 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.44792248 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40018636 |
| 97 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.36207319 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34281711 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33915918 |
| 100 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.32436480 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30404539 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29870921 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28287077 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28276428 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27124662 |
| 106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26956248 |
| 107 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.26800126 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26527459 |
| 109 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26519677 |
| 110 | AR_19668381_ChIP-Seq_PC3_Human | 1.26285913 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25601977 |
| 112 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.24961482 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24366017 |
| 114 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.23826395 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22961598 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21395404 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21058826 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20281949 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19769234 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19569935 |
| 121 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18437577 |
| 122 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18016448 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17794241 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17427067 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17295035 |
| 126 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17039527 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.14630013 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14270726 |
| 129 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13632768 |
| 130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13626126 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12842838 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12065978 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11066825 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10049302 |
| 135 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09870942 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09193290 |
| 137 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08502065 |
| 138 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08077705 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07994651 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06255649 |
| 141 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06201980 |
| 142 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05529894 |
| 143 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.05395337 |
| 144 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05105666 |
| 145 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05026565 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04757276 |
| 147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04328937 |
| 148 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03905984 |
| 149 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03166470 |
| 150 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01206565 |
| 151 | CBP_21632823_ChIP-Seq_H3396_Human | 1.00106668 |
| 152 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99939768 |
| 153 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99700329 |
| 154 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.99538286 |
| 155 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98930570 |
| 156 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97847330 |
| 157 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97847330 |
| 158 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97643057 |
| 159 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96925303 |
| 160 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96161853 |
| 161 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96035868 |
| 162 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95244615 |
| 163 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94484470 |
| 164 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94056249 |
| 165 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93850502 |
| 166 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92398582 |
| 167 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91167666 |
| 168 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90597673 |
| 169 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90307902 |
| 170 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90285541 |
| 171 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.90239156 |
| 172 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89864536 |
| 173 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89648728 |
| 174 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89155654 |
| 175 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87733860 |
| 176 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86624599 |
| 177 | VDR_22108803_ChIP-Seq_LS180_Human | 0.85196440 |
| 178 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.85022227 |
| 179 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84924265 |
| 180 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84749443 |
| 181 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84588511 |
| 182 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.83888997 |
| 183 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.83818534 |
| 184 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83734028 |
| 185 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83687588 |
| 186 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80534116 |
| 187 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79463604 |
| 188 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77608475 |
| 189 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76914792 |
| 190 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72963290 |
| 191 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72673385 |
| 192 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72349898 |
| 193 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71878892 |
| 194 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70679284 |
| 195 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.70513482 |
| 196 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.70458957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 6.65131989 |
| 2 | MP0002090_abnormal_vision | 5.17813133 |
| 3 | MP0001984_abnormal_olfaction | 4.87739111 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 4.61511504 |
| 5 | MP0003724_increased_susceptibility_to | 4.10988836 |
| 6 | MP0004233_abnormal_muscle_weight | 3.93841713 |
| 7 | MP0001502_abnormal_circadian_rhythm | 3.63305375 |
| 8 | MP0002638_abnormal_pupillary_reflex | 3.29538073 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.23971988 |
| 10 | MP0002132_abnormal_respiratory_system | 3.18106975 |
| 11 | MP0002163_abnormal_gland_morphology | 3.04038636 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.98751865 |
| 13 | MP0005253_abnormal_eye_physiology | 2.91518355 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.89802429 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.88646302 |
| 16 | MP0003436_decreased_susceptibility_to | 2.80533336 |
| 17 | MP0000685_abnormal_immune_system | 2.75394686 |
| 18 | MP0002419_abnormal_innate_immunity | 2.67386798 |
| 19 | MP0001800_abnormal_humoral_immune | 2.59821465 |
| 20 | MP0003303_peritoneal_inflammation | 2.59692251 |
| 21 | MP0005195_abnormal_posterior_eye | 2.52872200 |
| 22 | MP0001790_abnormal_immune_system | 2.48893690 |
| 23 | MP0005387_immune_system_phenotype | 2.48893690 |
| 24 | MP0006082_CNS_inflammation | 2.47079347 |
| 25 | MP0004782_abnormal_surfactant_physiolog | 2.41753868 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.39814370 |
| 27 | MP0004036_abnormal_muscle_relaxation | 2.38016599 |
| 28 | MP0001346_abnormal_lacrimal_gland | 2.35078412 |
| 29 | MP0008775_abnormal_heart_ventricle | 2.34934593 |
| 30 | MP0005000_abnormal_immune_tolerance | 2.30116521 |
| 31 | MP0004084_abnormal_cardiac_muscle | 2.28677273 |
| 32 | MP0003828_pulmonary_edema | 2.27910124 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.23957633 |
| 34 | MP0002723_abnormal_immune_serum | 2.22606518 |
| 35 | MP0002420_abnormal_adaptive_immunity | 2.16432344 |
| 36 | MP0005451_abnormal_body_composition | 2.15775990 |
| 37 | MP0005248_abnormal_Harderian_gland | 2.14355823 |
| 38 | MP0009785_altered_susceptibility_to | 2.14149885 |
| 39 | MP0003950_abnormal_plasma_membrane | 2.13181446 |
| 40 | MP0001819_abnormal_immune_cell | 2.12869882 |
| 41 | MP0005025_abnormal_response_to | 2.12387991 |
| 42 | MP0004381_abnormal_hair_follicle | 2.11746773 |
| 43 | MP0002396_abnormal_hematopoietic_system | 2.09564832 |
| 44 | MP0005671_abnormal_response_to | 2.04017813 |
| 45 | MP0003880_abnormal_central_pattern | 2.01005862 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 2.00235534 |
| 47 | MP0009046_muscle_twitch | 2.00147285 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.89638297 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.89385444 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.85370670 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.82503986 |
| 52 | MP0005394_taste/olfaction_phenotype | 1.81178642 |
| 53 | MP0005499_abnormal_olfactory_system | 1.81178642 |
| 54 | MP0002184_abnormal_innervation | 1.79398467 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.79372377 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.77240244 |
| 57 | MP0005670_abnormal_white_adipose | 1.77029977 |
| 58 | MP0002398_abnormal_bone_marrow | 1.76372958 |
| 59 | MP0003635_abnormal_synaptic_transmissio | 1.74236389 |
| 60 | MP0008789_abnormal_olfactory_epithelium | 1.71728736 |
| 61 | MP0002272_abnormal_nervous_system | 1.70706843 |
| 62 | MP0002405_respiratory_system_inflammati | 1.70663656 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.70636977 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.69302570 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.68579588 |
| 66 | MP0001851_eye_inflammation | 1.68320144 |
| 67 | MP0000716_abnormal_immune_system | 1.66661193 |
| 68 | MP0002229_neurodegeneration | 1.66487032 |
| 69 | MP0005595_abnormal_vascular_smooth | 1.59787336 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 1.57605715 |
| 71 | MP0001188_hyperpigmentation | 1.56400355 |
| 72 | MP0000858_altered_metastatic_potential | 1.55784064 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 1.55374429 |
| 74 | MP0004215_abnormal_myocardial_fiber | 1.54063771 |
| 75 | MP0002752_abnormal_somatic_nervous | 1.53627420 |
| 76 | MP0002064_seizures | 1.51910325 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.51549349 |
| 78 | MP0001486_abnormal_startle_reflex | 1.48167749 |
| 79 | MP0003045_fibrosis | 1.47753521 |
| 80 | MP0002063_abnormal_learning/memory/cond | 1.44250661 |
| 81 | MP0005164_abnormal_response_to | 1.43928454 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 1.43098589 |
| 83 | MP0003868_abnormal_feces_composition | 1.40874930 |
| 84 | MP0004883_abnormal_blood_vessel | 1.40237711 |
| 85 | MP0002234_abnormal_pharynx_morphology | 1.40216084 |
| 86 | MP0000569_abnormal_digit_pigmentation | 1.39800309 |
| 87 | MP0002722_abnormal_immune_system | 1.39411659 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.38663862 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 1.37741628 |
| 90 | MP0003879_abnormal_hair_cell | 1.36761627 |
| 91 | MP0004510_myositis | 1.32386352 |
| 92 | MP0004947_skin_inflammation | 1.31876558 |
| 93 | MP0002166_altered_tumor_susceptibility | 1.31102888 |
| 94 | MP0000689_abnormal_spleen_morphology | 1.30217954 |
| 95 | MP0005310_abnormal_salivary_gland | 1.29964001 |
| 96 | MP0000703_abnormal_thymus_morphology | 1.29875959 |
| 97 | MP0009697_abnormal_copulation | 1.28439827 |
| 98 | MP0004859_abnormal_synaptic_plasticity | 1.27291300 |
| 99 | MP0002429_abnormal_blood_cell | 1.26962500 |
| 100 | MP0002998_abnormal_bone_remodeling | 1.25894420 |
| 101 | MP0001968_abnormal_touch/_nociception | 1.25698569 |
| 102 | MP0003866_abnormal_defecation | 1.25205788 |
| 103 | MP0009745_abnormal_behavioral_response | 1.24691476 |
| 104 | MP0005391_vision/eye_phenotype | 1.23852865 |
| 105 | MP0003252_abnormal_bile_duct | 1.23659524 |
| 106 | MP0001529_abnormal_vocalization | 1.22811355 |
| 107 | MP0008260_abnormal_autophagy | 1.21491214 |
| 108 | MP0009278_abnormal_bone_marrow | 1.20807979 |
| 109 | MP0002882_abnormal_neuron_morphology | 1.19257088 |
| 110 | MP0008569_lethality_at_weaning | 1.19209294 |
| 111 | MP0002909_abnormal_adrenal_gland | 1.18811654 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 1.18026385 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 1.13853074 |
| 114 | MP0004130_abnormal_muscle_cell | 1.13650664 |
| 115 | MP0008469_abnormal_protein_level | 1.13063316 |
| 116 | MP0004808_abnormal_hematopoietic_stem | 1.12763753 |
| 117 | MP0004145_abnormal_muscle_electrophysio | 1.11645994 |
| 118 | MP0010368_abnormal_lymphatic_system | 1.10999719 |
| 119 | MP0002009_preneoplasia | 1.10965783 |
| 120 | MP0001324_abnormal_eye_pigmentation | 1.09054422 |
| 121 | MP0005666_abnormal_adipose_tissue | 1.07991351 |
| 122 | MP0001501_abnormal_sleep_pattern | 1.07913145 |
| 123 | MP0002736_abnormal_nociception_after | 1.04464286 |
| 124 | MP0001879_abnormal_lymphatic_vessel | 1.03382107 |
| 125 | MP0009764_decreased_sensitivity_to | 1.03093903 |
| 126 | MP0003011_delayed_dark_adaptation | 1.01936795 |
| 127 | MP0003195_calcinosis | 1.01701565 |
| 128 | MP0002572_abnormal_emotion/affect_behav | 1.01485860 |
| 129 | MP0005375_adipose_tissue_phenotype | 1.01366454 |
| 130 | MP0000343_altered_response_to | 0.98347619 |
| 131 | MP0005397_hematopoietic_system_phenotyp | 0.98096480 |
| 132 | MP0001545_abnormal_hematopoietic_system | 0.98096480 |
| 133 | MP0005423_abnormal_somatic_nervous | 0.97573575 |
| 134 | MP0002277_abnormal_respiratory_mucosa | 0.96304222 |
| 135 | MP0000751_myopathy | 0.94623609 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.93844861 |
| 137 | MP0002928_abnormal_bile_duct | 0.93781208 |
| 138 | MP0000015_abnormal_ear_pigmentation | 0.93444308 |
| 139 | MP0005166_decreased_susceptibility_to | 0.92528539 |
| 140 | MP0006276_abnormal_autonomic_nervous | 0.92294586 |
| 141 | MP0008057_abnormal_DNA_replication | 0.92256608 |
| 142 | MP0002933_joint_inflammation | 0.90828404 |
| 143 | MP0008874_decreased_physiological_sensi | 0.89911214 |
| 144 | MP0005620_abnormal_muscle_contractility | 0.89481866 |
| 145 | MP0000465_gastrointestinal_hemorrhage | 0.86872242 |
| 146 | MP0004742_abnormal_vestibular_system | 0.85133234 |
| 147 | MP0002089_abnormal_postnatal_growth/wei | 0.83714178 |
| 148 | MP0003448_altered_tumor_morphology | 0.83113264 |
| 149 | MP0004085_abnormal_heartbeat | 0.82996304 |
| 150 | MP0003656_abnormal_erythrocyte_physiolo | 0.82905060 |
| 151 | MP0002653_abnormal_ependyma_morphology | 0.82536296 |
| 152 | MP0004484_altered_response_of | 0.82276768 |
| 153 | MP0000955_abnormal_spinal_cord | 0.81987964 |
| 154 | MP0002822_catalepsy | 0.80318107 |
| 155 | MP0000372_irregular_coat_pigmentation | 0.78578340 |
| 156 | MP0002557_abnormal_social/conspecific_i | 0.78170452 |
| 157 | MP0005390_skeleton_phenotype | 0.76795221 |
| 158 | MP0003634_abnormal_glial_cell | 0.76513486 |
| 159 | MP0000534_abnormal_ureter_morphology | 0.75186080 |
| 160 | MP0005076_abnormal_cell_differentiation | 0.75145276 |
| 161 | MP0004811_abnormal_neuron_physiology | 0.74795112 |
| 162 | MP0006035_abnormal_mitochondrial_morpho | 0.73988903 |
| 163 | MP0005220_abnormal_exocrine_pancreas | 0.73770117 |
| 164 | MP0003890_abnormal_embryonic-extraembry | 0.73690402 |
| 165 | MP0003075_altered_response_to | 0.72413147 |
| 166 | MP0004142_abnormal_muscle_tone | 0.69777077 |
| 167 | MP0003091_abnormal_cell_migration | 0.68935230 |
| 168 | MP0009763_increased_sensitivity_to | 0.68070701 |
| 169 | MP0000013_abnormal_adipose_tissue | 0.66797660 |
| 170 | MP0003633_abnormal_nervous_system | 0.66760835 |
| 171 | MP0000566_synostosis | 0.66529644 |
| 172 | MP0000249_abnormal_blood_vessel | 0.63969354 |
| 173 | MP0000230_abnormal_systemic_arterial | 0.63353374 |
| 174 | MP0004043_abnormal_pH_regulation | 0.61579558 |
| 175 | MP0002006_tumorigenesis | 0.61401104 |
| 176 | MP0002066_abnormal_motor_capabilities/c | 0.61175121 |
| 177 | MP0002751_abnormal_autonomic_nervous | 0.61128640 |
| 178 | MP0002168_other_aberrant_phenotype | 0.60437341 |
| 179 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59925067 |
| 180 | MP0001873_stomach_inflammation | 0.59226409 |
| 181 | MP0002269_muscular_atrophy | 0.56904244 |
| 182 | MP0001915_intracranial_hemorrhage | 0.56800486 |
| 183 | MP0002735_abnormal_chemical_nociception | 0.56791643 |
| 184 | MP0008872_abnormal_physiological_respon | 0.56672131 |
| 185 | MP0000371_diluted_coat_color | 0.56629445 |
| 186 | MP0004270_analgesia | 0.55016810 |
| 187 | MP0003959_abnormal_lean_body | 0.54406047 |
| 188 | MP0003329_amyloid_beta_deposits | 0.53927917 |
| 189 | MP0001970_abnormal_pain_threshold | 0.53045083 |
| 190 | MP0002069_abnormal_eating/drinking_beha | 0.52011839 |
| 191 | MP0000003_abnormal_adipose_tissue | 0.51081570 |
| 192 | MP0005266_abnormal_metabolism | 0.50686350 |
| 193 | MP0004924_abnormal_behavior | 0.50335944 |
| 194 | MP0005386_behavior/neurological_phenoty | 0.50335944 |
| 195 | MP0002152_abnormal_brain_morphology | 0.48905615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Central scotoma (HP:0000603) | 7.93119077 |
| 2 | Severe visual impairment (HP:0001141) | 7.78670059 |
| 3 | Abnormality of macular pigmentation (HP:0008002) | 6.93587307 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.94511830 |
| 5 | Septo-optic dysplasia (HP:0100842) | 5.31712282 |
| 6 | Scotoma (HP:0000575) | 5.17740910 |
| 7 | Cholecystitis (HP:0001082) | 5.16931410 |
| 8 | Abnormal gallbladder physiology (HP:0012438) | 5.16931410 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.98772326 |
| 10 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.97752288 |
| 11 | Hypoplasia of the fovea (HP:0007750) | 4.97752288 |
| 12 | Decreased central vision (HP:0007663) | 4.70251286 |
| 13 | Increased corneal curvature (HP:0100692) | 4.67272550 |
| 14 | Keratoconus (HP:0000563) | 4.67272550 |
| 15 | Albinism (HP:0001022) | 4.52533847 |
| 16 | Recurrent abscess formation (HP:0002722) | 4.39763034 |
| 17 | Absence seizures (HP:0002121) | 4.24355237 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 4.22847542 |
| 19 | Febrile seizures (HP:0002373) | 4.22462487 |
| 20 | Eczematoid dermatitis (HP:0000976) | 4.10888092 |
| 21 | Orchitis (HP:0100796) | 4.07011793 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.99704358 |
| 23 | Optic neuritis (HP:0100653) | 3.99704358 |
| 24 | Abnormality of the fovea (HP:0000493) | 3.94856950 |
| 25 | Myositis (HP:0100614) | 3.93242178 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.93219696 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.80993590 |
| 28 | Abnormal pupillary function (HP:0007686) | 3.80700943 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 3.78926252 |
| 30 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.71234045 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.64718953 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.54798833 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.54798833 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52831883 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.51510837 |
| 36 | Keratoconjunctivitis (HP:0001096) | 3.51323407 |
| 37 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.47531128 |
| 38 | J-shaped sella turcica (HP:0002680) | 3.40637544 |
| 39 | Dialeptic seizures (HP:0011146) | 3.39878435 |
| 40 | Encephalitis (HP:0002383) | 3.37434311 |
| 41 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.31273583 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 3.27945449 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 3.20167649 |
| 44 | Hemiparesis (HP:0001269) | 3.18633679 |
| 45 | Meningitis (HP:0001287) | 3.17627654 |
| 46 | Recurrent skin infections (HP:0001581) | 3.12707535 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11040753 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 3.10904027 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07534849 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07534849 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07534849 |
| 52 | Prolonged bleeding time (HP:0003010) | 3.00232000 |
| 53 | Recurrent viral infections (HP:0004429) | 2.98362553 |
| 54 | Gingival bleeding (HP:0000225) | 2.93658747 |
| 55 | Vasculitis (HP:0002633) | 2.88408360 |
| 56 | Stomatitis (HP:0010280) | 2.83775790 |
| 57 | Prolonged QT interval (HP:0001657) | 2.79896409 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78793668 |
| 59 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.77502665 |
| 60 | Arterial thrombosis (HP:0004420) | 2.75062190 |
| 61 | Viral hepatitis (HP:0006562) | 2.70759150 |
| 62 | Increased IgE level (HP:0003212) | 2.67832363 |
| 63 | T lymphocytopenia (HP:0005403) | 2.67415493 |
| 64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.67407734 |
| 65 | Optic nerve hypoplasia (HP:0000609) | 2.67385861 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66301829 |
| 67 | Obstructive lung disease (HP:0006536) | 2.66301829 |
| 68 | Mutism (HP:0002300) | 2.66118546 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.62568955 |
| 70 | Panhypogammaglobulinemia (HP:0003139) | 2.62566857 |
| 71 | Generalized hypopigmentation (HP:0007513) | 2.58825663 |
| 72 | Absent septum pellucidum (HP:0001331) | 2.58214415 |
| 73 | Deformed sella turcica (HP:0002681) | 2.57489951 |
| 74 | Chest pain (HP:0100749) | 2.56067362 |
| 75 | Gingivitis (HP:0000230) | 2.54443270 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.53355125 |
| 77 | Epistaxis (HP:0000421) | 2.53291740 |
| 78 | Epileptiform EEG discharges (HP:0011182) | 2.51296838 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.50814900 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.49838081 |
| 81 | Generalized tonic-clonic seizures (HP:0002069) | 2.48924731 |
| 82 | Dysdiadochokinesis (HP:0002075) | 2.48333711 |
| 83 | Colitis (HP:0002583) | 2.46541197 |
| 84 | Subacute progressive viral hepatitis (HP:0006572) | 2.45187087 |
| 85 | Peritonitis (HP:0002586) | 2.44541829 |
| 86 | Hemoptysis (HP:0002105) | 2.43026757 |
| 87 | Attenuation of retinal blood vessels (HP:0007843) | 2.34042634 |
| 88 | Exercise-induced myalgia (HP:0003738) | 2.31349021 |
| 89 | Abnormality of abdominal situs (HP:0011620) | 2.30757653 |
| 90 | Abdominal situs inversus (HP:0003363) | 2.30757653 |
| 91 | Recurrent bronchitis (HP:0002837) | 2.30032937 |
| 92 | Pulmonary infiltrates (HP:0002113) | 2.27686981 |
| 93 | Leukocytosis (HP:0001974) | 2.24606882 |
| 94 | Recurrent pneumonia (HP:0006532) | 2.24560137 |
| 95 | Cellulitis (HP:0100658) | 2.23956825 |
| 96 | Flat acetabular roof (HP:0003180) | 2.23434243 |
| 97 | Abnormality of T cells (HP:0002843) | 2.22842274 |
| 98 | Ventricular fibrillation (HP:0001663) | 2.22751294 |
| 99 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22491159 |
| 100 | Abnormality of alanine metabolism (HP:0010916) | 2.22491159 |
| 101 | Hyperalaninemia (HP:0003348) | 2.22491159 |
| 102 | Congenital sensorineural hearing impairment (HP:0008527) | 2.18927140 |
| 103 | Thoracolumbar scoliosis (HP:0002944) | 2.17018005 |
| 104 | Severe Myopia (HP:0011003) | 2.16288029 |
| 105 | Glucose intolerance (HP:0000833) | 2.16193728 |
| 106 | Episodic fever (HP:0001954) | 2.16007483 |
| 107 | Osteomyelitis (HP:0002754) | 2.15407252 |
| 108 | Abnormality of the septum pellucidum (HP:0007375) | 2.13322087 |
| 109 | Abnormality of the lower motor neuron (HP:0002366) | 2.12914939 |
| 110 | Neoplasm of the heart (HP:0100544) | 2.11942204 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 2.11107137 |
| 112 | Abnormality of B cell number (HP:0010975) | 2.09808622 |
| 113 | Fatigue (HP:0012378) | 2.09663895 |
| 114 | Supranuclear gaze palsy (HP:0000605) | 2.09155041 |
| 115 | Urticaria (HP:0001025) | 2.08209525 |
| 116 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08154539 |
| 117 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.06728657 |
| 118 | Hand muscle atrophy (HP:0009130) | 2.06240213 |
| 119 | Gangrene (HP:0100758) | 2.05530330 |
| 120 | Astigmatism (HP:0000483) | 2.05514861 |
| 121 | Retinal dysplasia (HP:0007973) | 2.03820161 |
| 122 | B lymphocytopenia (HP:0010976) | 2.03599878 |
| 123 | Agammaglobulinemia (HP:0004432) | 2.01460272 |
| 124 | Increased connective tissue (HP:0009025) | 2.00279273 |
| 125 | Congenital stationary night blindness (HP:0007642) | 15.9641277 |
| 126 | Myocardial infarction (HP:0001658) | 1.99767395 |
| 127 | Sepsis (HP:0100806) | 1.99727468 |
| 128 | Granulocytopenia (HP:0001913) | 1.98558054 |
| 129 | Hematochezia (HP:0002573) | 1.98502959 |
| 130 | Gait imbalance (HP:0002141) | 1.98073979 |
| 131 | Acute hepatic failure (HP:0006554) | 1.96402016 |
| 132 | Anorexia (HP:0002039) | 1.95528838 |
| 133 | Retinitis pigmentosa (HP:0000510) | 1.95212195 |
| 134 | Abnormality of the endocardium (HP:0004306) | 1.94579386 |
| 135 | Unsteady gait (HP:0002317) | 1.93927465 |
| 136 | Photophobia (HP:0000613) | 1.92770483 |
| 137 | Dysmetric saccades (HP:0000641) | 1.91447323 |
| 138 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.90182666 |
| 139 | Subaortic stenosis (HP:0001682) | 1.90182666 |
| 140 | Abnormality of T cell physiology (HP:0011840) | 1.89647775 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.89285453 |
| 142 | Easy fatigability (HP:0003388) | 1.89186318 |
| 143 | Depression (HP:0000716) | 1.89058438 |
| 144 | Pulmonary embolism (HP:0002204) | 1.88825851 |
| 145 | Eosinophilia (HP:0001880) | 1.88472950 |
| 146 | Congenital primary aphakia (HP:0007707) | 1.87634303 |
| 147 | Keratitis (HP:0000491) | 1.87354380 |
| 148 | Long toe (HP:0010511) | 1.85974344 |
| 149 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85722040 |
| 150 | Pustule (HP:0200039) | 1.85024040 |
| 151 | Hepatosplenomegaly (HP:0001433) | 1.84389921 |
| 152 | Neurodegeneration (HP:0002180) | 1.82645685 |
| 153 | Hyporeflexia of lower limbs (HP:0002600) | 1.80781825 |
| 154 | Increased IgM level (HP:0003496) | 1.80526244 |
| 155 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79849027 |
| 156 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79849027 |
| 157 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79849027 |
| 158 | Abnormality of the pleura (HP:0002103) | 1.79754152 |
| 159 | Purpura (HP:0000979) | 1.79295560 |
| 160 | Growth hormone deficiency (HP:0000824) | 1.78401745 |
| 161 | Papilledema (HP:0001085) | 1.78048391 |
| 162 | Cerebellar dysplasia (HP:0007033) | 1.77868779 |
| 163 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76214566 |
| 164 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76194361 |
| 165 | Lymphopenia (HP:0001888) | 1.76141608 |
| 166 | Abnormal EKG (HP:0003115) | 1.72325075 |
| 167 | Cholelithiasis (HP:0001081) | 1.71148790 |
| 168 | Myoglobinuria (HP:0002913) | 1.70993870 |
| 169 | Primary adrenal insufficiency (HP:0008207) | 1.69209142 |
| 170 | Medial flaring of the eyebrow (HP:0010747) | 1.68757255 |
| 171 | Widely spaced teeth (HP:0000687) | 1.67888759 |
| 172 | Type II diabetes mellitus (HP:0005978) | 1.67740249 |
| 173 | Syncope (HP:0001279) | 1.67511633 |
| 174 | Partial agenesis of the corpus callosum (HP:0001338) | 1.65292354 |
| 175 | Sex reversal (HP:0012245) | 1.65185422 |
| 176 | Abnormal sex determination (HP:0012244) | 1.65185422 |
| 177 | Pendular nystagmus (HP:0012043) | 1.64403260 |
| 178 | Exercise-induced muscle cramps (HP:0003710) | 1.64139764 |
| 179 | Scanning speech (HP:0002168) | 1.62328758 |
| 180 | Atrial fibrillation (HP:0005110) | 1.60679024 |
| 181 | Gaze-evoked nystagmus (HP:0000640) | 1.60351496 |
| 182 | Abnormality of the sella turcica (HP:0002679) | 1.57184930 |
| 183 | Upper limb amyotrophy (HP:0009129) | 1.56848673 |
| 184 | Distal upper limb amyotrophy (HP:0007149) | 1.56848673 |
| 185 | Visual hallucinations (HP:0002367) | 1.56451250 |
| 186 | Decreased circulating renin level (HP:0003351) | 1.56413581 |
| 187 | Maternal diabetes (HP:0009800) | 1.55685290 |
| 188 | Chorioretinal coloboma (HP:0000567) | 1.55328249 |
| 189 | Polyphagia (HP:0002591) | 1.55303550 |
| 190 | Flat cornea (HP:0007720) | 1.54548688 |
| 191 | Arterial tortuosity (HP:0005116) | 1.54377224 |
| 192 | Gastrointestinal dysmotility (HP:0002579) | 1.53889631 |
| 193 | True hermaphroditism (HP:0010459) | 1.52773078 |
| 194 | Abnormal gallbladder morphology (HP:0012437) | 1.51668823 |
| 195 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.50730768 |
| 196 | Spondylolisthesis (HP:0003302) | 1.50278334 |
| 197 | Limb ataxia (HP:0002070) | 1.49166748 |
| 198 | Volvulus (HP:0002580) | 1.49088711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.49371828 |
| 2 | NEK1 | 4.21919125 |
| 3 | BLK | 3.85046603 |
| 4 | RIPK4 | 3.71502503 |
| 5 | NME1 | 3.48077878 |
| 6 | MAP2K3 | 3.27111385 |
| 7 | MAP3K13 | 3.20385207 |
| 8 | RIPK1 | 3.03114600 |
| 9 | STK38L | 3.02261271 |
| 10 | PRPF4B | 3.00950807 |
| 11 | PAK6 | 2.96738096 |
| 12 | TAOK2 | 2.88284397 |
| 13 | ERN1 | 2.69767949 |
| 14 | MAP3K4 | 2.62279293 |
| 15 | STK38 | 2.60807978 |
| 16 | IRAK4 | 2.55944990 |
| 17 | MAP4K1 | 2.39691164 |
| 18 | DYRK1A | 2.37283341 |
| 19 | PHKG2 | 2.33874211 |
| 20 | PHKG1 | 2.33874211 |
| 21 | MINK1 | 2.18848696 |
| 22 | PINK1 | 2.16297180 |
| 23 | TYK2 | 2.07648302 |
| 24 | MARK1 | 1.92062122 |
| 25 | MAP3K3 | 1.86340596 |
| 26 | EPHA4 | 1.85450715 |
| 27 | MAP3K14 | 1.84282206 |
| 28 | INSRR | 1.81742325 |
| 29 | CDK12 | 1.78939240 |
| 30 | PIK3CG | 1.78348915 |
| 31 | ZAP70 | 1.75208178 |
| 32 | FES | 1.72646218 |
| 33 | CSK | 1.70670992 |
| 34 | MAP3K7 | 1.70507859 |
| 35 | TAOK3 | 1.53731095 |
| 36 | TNK2 | 1.52429334 |
| 37 | JAK3 | 1.49912436 |
| 38 | CAMK2D | 1.48930296 |
| 39 | CAMK1D | 1.46403083 |
| 40 | KDR | 1.46192730 |
| 41 | FGR | 1.46177427 |
| 42 | MUSK | 1.45712902 |
| 43 | KIT | 1.45121010 |
| 44 | PRKAA1 | 1.44992595 |
| 45 | HCK | 1.41448651 |
| 46 | IKBKE | 1.40024711 |
| 47 | MAP3K10 | 1.37586888 |
| 48 | SYK | 1.34741010 |
| 49 | EPHB1 | 1.30748421 |
| 50 | YES1 | 1.30340851 |
| 51 | CLK1 | 1.29504514 |
| 52 | MAP3K1 | 1.29087454 |
| 53 | STK24 | 1.26206635 |
| 54 | PKN2 | 1.20744657 |
| 55 | MELK | 1.19333404 |
| 56 | JAK1 | 1.18468437 |
| 57 | TXK | 1.17604373 |
| 58 | TBK1 | 1.17392064 |
| 59 | BTK | 1.15662180 |
| 60 | JAK2 | 1.14668565 |
| 61 | FER | 1.14337905 |
| 62 | LYN | 1.13756869 |
| 63 | CDK3 | 1.09293797 |
| 64 | MAP3K5 | 1.08084799 |
| 65 | CSF1R | 1.05975156 |
| 66 | MAP3K9 | 1.02533791 |
| 67 | PAK3 | 1.01997716 |
| 68 | EPHA3 | 1.01788966 |
| 69 | NEK9 | 1.00223072 |
| 70 | IRAK2 | 0.98619470 |
| 71 | BRD4 | 0.98510178 |
| 72 | CDK14 | 0.98496258 |
| 73 | MAP2K7 | 0.93921135 |
| 74 | CAMK1 | 0.93882559 |
| 75 | CAMK1G | 0.93315863 |
| 76 | TAOK1 | 0.91112117 |
| 77 | RPS6KB2 | 0.89047749 |
| 78 | BMPR2 | 0.88667460 |
| 79 | IKBKB | 0.88233356 |
| 80 | ITK | 0.86647069 |
| 81 | DYRK1B | 0.84871874 |
| 82 | DAPK2 | 0.82979200 |
| 83 | TRIB3 | 0.82232960 |
| 84 | MAP3K2 | 0.81423521 |
| 85 | GRK6 | 0.80195765 |
| 86 | MAPK7 | 0.79622687 |
| 87 | PDK1 | 0.79597430 |
| 88 | MARK3 | 0.79143132 |
| 89 | STK10 | 0.78649031 |
| 90 | SGK494 | 0.77816372 |
| 91 | SGK223 | 0.77816372 |
| 92 | CDK6 | 0.77521518 |
| 93 | IRAK3 | 0.76456938 |
| 94 | PKN1 | 0.74555313 |
| 95 | ICK | 0.73983149 |
| 96 | MAP3K6 | 0.72596501 |
| 97 | MAPK12 | 0.71632031 |
| 98 | LCK | 0.71440813 |
| 99 | RET | 0.71405563 |
| 100 | PRKCE | 0.70801811 |
| 101 | SIK3 | 0.70779817 |
| 102 | AKT3 | 0.70767460 |
| 103 | ROCK2 | 0.69812653 |
| 104 | PRKG1 | 0.69609696 |
| 105 | FLT3 | 0.68869709 |
| 106 | PRKCG | 0.68520309 |
| 107 | CAMK2A | 0.67452141 |
| 108 | CDK15 | 0.67237627 |
| 109 | FRK | 0.67051218 |
| 110 | RAF1 | 0.65752547 |
| 111 | KSR1 | 0.65716756 |
| 112 | PRKD2 | 0.65310469 |
| 113 | HIPK2 | 0.64192663 |
| 114 | MAP3K11 | 0.62165795 |
| 115 | TEC | 0.61993663 |
| 116 | CDK18 | 0.61137989 |
| 117 | CDK8 | 0.60835327 |
| 118 | PTK2B | 0.60784317 |
| 119 | TNIK | 0.60724447 |
| 120 | PRKCQ | 0.60037220 |
| 121 | TRPM7 | 0.59708895 |
| 122 | CDK4 | 0.59449506 |
| 123 | PDPK1 | 0.58428198 |
| 124 | PRKCA | 0.58196686 |
| 125 | CDK11A | 0.57012676 |
| 126 | MOS | 0.56425307 |
| 127 | MAPK10 | 0.56005701 |
| 128 | CDK5 | 0.55987126 |
| 129 | WNK3 | 0.55552895 |
| 130 | MAP2K6 | 0.55039374 |
| 131 | NEK6 | 0.54721953 |
| 132 | PRKG2 | 0.54411621 |
| 133 | BMX | 0.53523077 |
| 134 | WNK1 | 0.52270206 |
| 135 | PRKCZ | 0.51939027 |
| 136 | NLK | 0.51499891 |
| 137 | MARK2 | 0.51339325 |
| 138 | MATK | 0.50551535 |
| 139 | PRKACA | 0.50483876 |
| 140 | NTRK2 | 0.48551812 |
| 141 | LRRK2 | 0.48261486 |
| 142 | PRKCB | 0.47698691 |
| 143 | RPS6KA3 | 0.45965568 |
| 144 | PIM1 | 0.44732076 |
| 145 | PLK3 | 0.44623982 |
| 146 | BCKDK | 0.43047490 |
| 147 | FGFR3 | 0.42972228 |
| 148 | CAMK4 | 0.41303878 |
| 149 | PRKAA2 | 0.41016183 |
| 150 | GSK3B | 0.38772782 |
| 151 | ERBB2 | 0.38482933 |
| 152 | RPS6KL1 | 0.38101253 |
| 153 | RPS6KC1 | 0.38101253 |
| 154 | MAPK13 | 0.37603565 |
| 155 | ARAF | 0.36736219 |
| 156 | MAPK9 | 0.36036587 |
| 157 | STK4 | 0.35999721 |
| 158 | RPS6KA5 | 0.35141383 |
| 159 | ERBB3 | 0.34751385 |
| 160 | PRKACB | 0.34386902 |
| 161 | MAP2K4 | 0.34156656 |
| 162 | RPS6KA6 | 0.34128574 |
| 163 | RPS6KA4 | 0.33756673 |
| 164 | FGFR1 | 0.33452011 |
| 165 | KSR2 | 0.33286968 |
| 166 | MAPK8 | 0.32089843 |
| 167 | PRKD3 | 0.31776272 |
| 168 | BRAF | 0.31670564 |
| 169 | MAPK1 | 0.31101742 |
| 170 | CAMKK1 | 0.31010558 |
| 171 | PRKACG | 0.30728096 |
| 172 | ROCK1 | 0.29867526 |
| 173 | TSSK6 | 0.27305663 |
| 174 | CASK | 0.25931510 |
| 175 | MAPK14 | 0.25838614 |
| 176 | IRAK1 | 0.24669187 |
| 177 | AKT2 | 0.22213280 |
| 178 | CSNK1E | 0.20825191 |
| 179 | CDC42BPA | 0.20151424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.28551830 |
| 2 | * GABAergic synapse_Homo sapiens_hsa04727 | 3.74337928 |
| 3 | Circadian rhythm_Homo sapiens_hsa04710 | 3.72079041 |
| 4 | * Morphine addiction_Homo sapiens_hsa05032 | 3.27021169 |
| 5 | * Nicotine addiction_Homo sapiens_hsa05033 | 3.07464351 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.03870968 |
| 7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.75537180 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72732382 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54314350 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50898932 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48551767 |
| 12 | Renin secretion_Homo sapiens_hsa04924 | 2.46422023 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.30909229 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.27693110 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27334453 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.26769962 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.19385350 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.02593281 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.98006605 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92018965 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.91578778 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.90903061 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.90501483 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.88769815 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.87231641 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86098972 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84985577 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.82254845 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.79322553 |
| 30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78931302 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.78255964 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76062701 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.76027301 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74144531 |
| 35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.73006114 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.72126223 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69078626 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66392006 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63177576 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63032405 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61777307 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.59690688 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58843251 |
| 44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.58830437 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58118418 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56660354 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56615702 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56355639 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56009651 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52669383 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.51837975 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50881384 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.47710880 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.45775698 |
| 55 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.44724404 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41546060 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.41219798 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39045727 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38875039 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38500539 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35396324 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.34044408 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 1.32768039 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 1.32545324 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 1.31708137 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27219742 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26155767 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25401380 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22102474 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21742317 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17678500 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17206630 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 1.16909705 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 1.14551154 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10349816 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09844682 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09082873 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06068892 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 1.03461357 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 1.03458977 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 1.02494428 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02038995 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 1.01734329 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99757975 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99487737 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.94329932 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94077466 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93813564 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92759321 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92407072 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91601684 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90798328 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89252568 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88094391 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86394984 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.85964095 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85143540 |
| 98 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83367148 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82042773 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81483307 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79956484 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79018689 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78105975 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75863312 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.75851064 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.75202667 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72760848 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72561349 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70884399 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.70421433 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69520118 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69274877 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66830015 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66624690 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.66262529 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65973878 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62896716 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62731695 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62277729 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61990996 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61856042 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61826905 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60844534 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.59752769 |
| 125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58734427 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.57928108 |
| 127 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57061807 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.56171157 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.55530376 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.55472839 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55053820 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55049367 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53689374 |
| 134 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53614083 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52900070 |
| 136 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52518221 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50577030 |
| 138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50569080 |
| 139 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48639431 |
| 140 | ABC transporters_Homo sapiens_hsa02010 | 0.48202602 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47317407 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46134746 |
| 143 | Long-term depression_Homo sapiens_hsa04730 | 0.45073099 |
| 144 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43810459 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43276956 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42588267 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42569288 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40451590 |
| 149 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39213624 |
| 150 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38793126 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36994886 |
| 152 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36746097 |
| 153 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35874724 |
| 154 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35423614 |
| 155 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35254543 |
| 156 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33369897 |
| 157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31223240 |
| 158 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30561559 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27533155 |
| 160 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27490501 |
| 161 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27209844 |
| 162 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26960865 |
| 163 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26202670 |
| 164 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25802560 |
| 165 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25377235 |
| 166 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25238808 |
| 167 | Purine metabolism_Homo sapiens_hsa00230 | 0.24932915 |
| 168 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.24233262 |
| 169 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23989962 |
| 170 | Lysosome_Homo sapiens_hsa04142 | 0.22072381 |
| 171 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21444538 |
| 172 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18696309 |
| 173 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18129608 |
| 174 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17413034 |
| 175 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16906172 |
| 176 | Colorectal cancer_Homo sapiens_hsa05210 | 0.15179768 |
| 177 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.13955970 |
| 178 | Endocytosis_Homo sapiens_hsa04144 | 0.11674270 |
| 179 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11444818 |
| 180 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.11266132 |

